H3 histone pseudogene 21 (H3P21)

H3 histone pseudogene 21 is annotated in human genomic databases as a **histone H3 pseudogene**, with aliases including p01 and H3.Z. True histone variants such as H3.Y are known to have functional roles in chromatin accessibility and transcription regulation, especially around transcription start sites, and are implicated in cellular differentiation and stress responses, but **H3P21 itself is classified as a pseudogene** and may not encode a functional protein or have direct biological activity[1][2]. Some histone pseudogenes are transcribed and might have regulatory functions at the RNA level, but there is currently **no evidence that H3P21 acts as a therapeutic target, nor is it recognized as a receptor, enzyme, transporter, or similar druggable entity**[2]. Its main relevance is as a genomic element in the study of histone gene evolution and diversity in mammals. **Critical annotation notes:** - The presence of multiple aliases and a lack of clear, experimentally validated function indicates that this is not a canonical target for drugs or therapeutics. - Some genomic databases may annotate H3P21 as a “pseudogene” reflecting lack of protein-coding potential or function. - Histone pseudogenes are generally *not considered targets* in the context of drug discovery or biomarker development[2]. - The biological and disease relevance of pseudogenes remains under investigation, with most not having established roles. **Summary for structured data conversion:** - H3 histone pseudogene 21 is most accurately considered a non-target pseudogene, with no validated function, drug interaction, disease role, or biomarker status, and its entries in genomic databases may be ambiguous or redundant[2]. Direct therapeutic or safety relevance is absent. If biological activity is suspected or further evidence emerges, the entity should be reassessed.

Other names

p01H3.ZH3P21

Not applicable